Lacey, J., J. Hewitt, J. L. Daley-Morris, J. James, J. Stevens, and O. Blaizel. “Expert Clinical Framework Report: Management of Adverse Events Related to Novel Therapies for relapsed/Refractory Multiple Myeloma (RRMM)”. Canadian Hematology Today, vol. 1, no. S11, Nov. 2022, doi:10.58931/cht.2022.1S1130.